Target intelligence / Profile preview

FSHD region gene 2 family member L, pseudogene (FRG2LP)

Target: FRG2LP
Molecular classification: Other (Pseudogene)

Overview

FSHD region gene 2 family member L, pseudogene (FRG2LP) is classified as a pseudogene associated with the FRG2 gene family, which includes genes located proximal to the D4Z4 repeat array involved in facioscapulohumeral muscular dystrophy (FSHD)[1]. FRG2 itself has been investigated for its possible role in FSHD, but the FRG2LP gene is annotated as a pseudogene, which means it is not expected to code for a functional protein. There is currently no evidence of established biological activity, therapeutic relevance, or pharmacological targeting for FRG2LP in the literature or disease gene databases[1].

Other names: FRG2LP

Beyond the preview

Go deeper on FSHD region gene 2 family member L, pseudogene (FRG2LP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FSHD region gene 2 family member L, pseudogene (FRG2LP).

Explore the full profile